Malignant Middle Cerebral Artery Infarction Decompressive Craniectomy Score: A Prognostic Model for Malignant Middle

Modar Alhamdan1, Alba Corell2, Klas Holmgren3

  • 1Department of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.

World Neurosurgery
|March 29, 2026
PubMed
Abstract

Insights

A new score helps predict outcomes for malignant middle cerebral artery infarction patients after decompressive hemicraniectomy. The MMI-DC (MAD) score identifies key predictors to guide patient prognostication and care.

Area of Science:

  • Neurology
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Malignant middle cerebral artery infarction (MMI) presents a high risk of mortality and disability.
  • Decompressive hemicraniectomy (DC) is a life-saving procedure but patient outcomes vary significantly.
  • Predictive tools for prognostication after DC in MMI patients are currently lacking.

Purpose of the Study:

  • To identify independent predictors of outcome in MMI patients undergoing DC.
  • To develop a pragmatic, bedside prognostic tool for MMI patients treated with DC.

Main Methods:

  • Retrospective analysis of 318 MMI patients treated with DC across four Swedish university hospitals (2008-2022).
  • Data collection included demographic, preoperative, and postoperative variables.
  • Ordinal logistic regression analysis was used to identify predictors of 6-month modified Rankin Scale (mRS), forming the MMI-DC (MAD) score.

Main Results:

  • A significant proportion of patients (76%) had unfavorable outcomes (mRS 4-6) at 6 months post-DC.
  • The MAD score incorporates age (≥60), female sex, low Glasgow Coma Scale (GCS M <4), and impaired pupillary reactivity.
  • Higher MAD scores correlated with significantly worse functional outcomes and increased mortality rates.

Conclusions:

  • Decompressive hemicraniectomy for MMI is associated with a high rate of unfavorable outcomes.
  • The MMI-DC (MAD) score demonstrates internal reliability as a prognostic tool for MMI patients undergoing DC.
  • Further external validation of the MAD score and investigation into the predictive value of female sex are warranted.

Related Concept Videos